Search results
Author(s):
Alexander Feldman
,
Jonathan M Kalman
Added:
3 years ago
Focal atrial tachycardia (AT) is the least common type of supraventricular tachycardia, accounting for 5–15% of cases presenting to the electrophysiology (EP) laboratory for ablation.1 Focal AT is defined by the presence of a discrete atrial focus with centrifugal spread of atrial activation away from that site.2 It is generally poorly responsive to pharmacological therapy and may be responsible…
View more
Author(s):
Andreas Pflaumer
,
Gabriele Hessling
Added:
3 years ago
Advances in the treatment of complex congenital heart disease over the past 20 years have led to a dramatic improvement in long-term survival.1 However, the incidence of cardiac arrhythmias as a sequel of palliative heart surgery has also increased significantly in adolescent and adult survivors of congenital heart disease surgery.1,2 Cardiac arrhythmias are the leading cause of emergency…
View more
ESC 23: The SurHyb Trial
Author(s):
Alan Bulava
Added:
7 months ago
Video
Author(s):
Joachim R Ehrlich
Added:
5 years ago
Improving EP Lab efficiency Optimising EP Lab Efficiency with Cryoballoon
Prof. Dr. med. Joachim Ehrlich
Filmed by Radcliffe Cardiology on site EHRA 2018.
View more
Author(s):
Aaisha Opel
Added:
5 years ago
Dr Aaisha Opel discusses 'Empowering Teams to Improve Atrial Fibrillaiton Ablation Efficiency and Outcomes' at EHRA 2018.
Filmed by Radcliffe Cardiology on site EHRA 2018.
View more
Author(s):
Johannes Sperzel
Added:
6 years ago
ProfSperzel (Bad Nauheim, GER) describes a systematic and efficient way to optimise patient selection at risk for SCD.
Katalon Recorder is recording ...
Stop
View more
EHRA 2018: Strategies for Treating Newly Diagnosed Heart Failure Patients – GDTM, the WCD and Time
Author(s):
Daniel Scherr
Added:
5 years ago
Video
Author(s):
Niels Voigt
,
Dobromir Dobrev
Added:
3 years ago
Atrial fibrillation (AF) is common and is associated with significant cardiovascular morbidity and mortality, with stroke being the most critical complication.1,2 Drugs presently used for AF therapy have major limitations, including incomplete efficacy and risks of life-threatening proarrhythmic events (antiarrhythmic drugs) and bleeding complications (anticoagulants).3 Non-pharmacological…
View more